ACTIVE_NOT_RECRUITING

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.

Official Title

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Quick Facts

Study Start:2024-02-12
Study Completion:2026-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06225414

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 50- 80 years of age.
  2. * Be able to speak English and Spanish
  3. * Must have a Primary Care Provider.
  4. * History of 20-pack year smoking history ( based on survey self-report)
  5. * Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self-report)
  6. * Resident of California
  1. * Prior history of lung cancer
  2. * Chest CT for any reason in the last 12 months based on self-report and UCI EMR
  3. * History of Alzheimer's disease or dementia

Contacts and Locations

Principal Investigator

Gelareh Sadigh, MD
PRINCIPAL_INVESTIGATOR
University of California, Irvine

Study Locations (Sites)

UCI Health Family Health Center - Anaheim
Anaheim, California, 92801
United States
UCI Health-Costa Mesa
Costa Mesa, California, 92627
United States
UCI Health-Irvine
Irvine, California, 92612
United States
UCI Health-Laguna hilla
Laguna Hills, California, 92653
United States
UCI Health-Newport
Newport Beach, California, 92660
United States
UCI Health SeniorHealth Center -Pavillion 4
Orange, California, 92868
United States
UCI Medical Center, Pavilion 3
Orange, California, 92868
United States
UCI Health Family Health Center - Santa Ana
Santa Ana, California, 92701
United States
UCI-Health Tustin
Tustin, California, 92780
United States
UCI Health-Yorba Linda
Yorba Linda, California, 92886
United States

Collaborators and Investigators

Sponsor: University of California, Irvine

  • Gelareh Sadigh, MD, PRINCIPAL_INVESTIGATOR, University of California, Irvine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-12
Study Completion Date2026-02

Study Record Updates

Study Start Date2024-02-12
Study Completion Date2026-02

Terms related to this study

Keywords Provided by Researchers

  • Lung Cancer
  • Screening
  • Multi-level intervention

Additional Relevant MeSH Terms

  • Lung Cancer